P. Braitstein, M. Brinkhof, and F. Dabis, Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries, Lancet, vol.367, pp.817-824, 2006.

A. Canestri, B. Taverne, and S. Thiam, Direct, Extra-ARV Medical Follow-Up Costs for Patients The Senegalese Antiretroviral Drug Access Initiative, An Economic, Social, Behavioural and Biomedical Analysis, pp.49-59, 2004.

A. Desclaux, I. Laniece, I. Ndoye, and B. Taverne, The Senegalese Antiretroviral Drug Access Initiative. An Economic, Social, Behavioural and Biomedical Analysis, p.230, 2004.

J. Etard, I. Ndiaye, T. Mieg, and M. , Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study, AIDS, vol.20, issue.8, pp.1181-1189, 2006.
DOI : 10.1097/01.aids.0000226959.87471.01

C. Gilks, S. Crowley, and R. Ekpini, The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings, The Lancet, vol.368, issue.9534, pp.505-510, 2006.
DOI : 10.1016/S0140-6736(06)69158-7

E. S. Gomes-(-do, Étude sur l'équité dans l'accès aux soins de santé et les déterminants socio-économiques des recours aux soins dans la région de Dakar: Ministère de la Santé, FNUAP, 2000.

R. Laguide, N. Elengua, and P. Fassinou, Direct Costs of Medical Care for HIV-Infected Children Before and During HAART in Abidjan, Côte d'Ivoire Economics of AIDS and Access to HIV/AIDS Care in Developing Countries. Issues and Challenges, pp.311-327, 2000.

I. Laniece, M. Ciss, and A. Desclaux, Adherence to HAART and its principal determinants in a cohort of Senegalese adults. Aids, pp.103-108, 2003.

D. Mcintyre, M. Thiede, G. Dahlgren, and M. Whitehead, What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?, Social Science & Medicine, vol.62, issue.4, pp.858-865, 2006.
DOI : 10.1016/j.socscimed.2005.07.001

N. Meda, I. Ndoye, M. Boup, and S. , Low and stable HIV infection rates in Senegal: natural course of the epidemic or evidence for success of prevention?, AIDS, vol.13, issue.11, pp.1397-405, 1999.
DOI : 10.1097/00002030-199907300-00018

B. Meessen, W. Van-damme, C. Tashobya, and A. Tibouti, Poverty and user fees for public health care in low-income countries: lessons from Uganda and Cambodia, The Lancet, vol.368, issue.9554, pp.2253-2260, 2006.
DOI : 10.1016/S0140-6736(06)69899-1

J. Nabyonga, M. Desmet, and H. Karamagi, Abolition of cost-sharing is pro-poor: evidence from Uganda, Health Policy and Planning, vol.20, issue.2, pp.100-108, 2005.
DOI : 10.1093/heapol/czi012

P. Vinard, M. Ciss, B. Taverne, A. Ly, and I. Ndoye, Analysis of HIV/AIDS Expenditures in Senegal: from Pilot Project to National Program Economics of AIDS and Access to HIV/AIDS Care in Developping Countries. Issues and Challenges, pp.459-482, 2003.

A. Whiteside and S. Lee, The ???Free by 5??? Campaign for Universal, Free Antiretroviral Therapy, PLoS Medicine, vol.34, issue.8, p.227, 2005.
DOI : 10.1371/journal.pmed.0020227.g001